Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q3 2015

Baupost Group

Portfolio at the end of Q3 2015, from the 13F filed November 13, 2015. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Cheniere Energy LNG · history 18.2% $1.09B 22,669,730 $48.30 Q1 2014 Add 48%
Viasat VSAT · history 12.4% $741.5M 11,533,137 $64.29 Q2 2013 or earlier No change
Alcoa AA · history 8.4% $504.9M 52,270,000 $9.66 Q3 2015 Buy
Pioneer Natural Resources PXD · history 8.4% $503.2M 4,137,000 $121.64 Q1 2015 Add 2%
Antero Resources AR · history 5.7% $340.7M 16,099,763 $21.16 Q3 2014 Add 101%
PayPal PYPL · history 5.6% $338.5M 10,904,852 $31.04 Q3 2015 Buy
PBF Energy PBF · history 5.2% $311.2M 11,025,000 $28.23 Q3 2013 No change
eBay EBAY · history 3.8% $227.7M 9,315,000 $24.44 Q2 2014 No change
Twenty-First Century Fox FOX · history 2.9% $176.7M 6,527,500 $27.07 Q3 2015 Buy
Atara Biotherapeutics ATRA · history 2.8% $168.5M 5,359,632 $31.44 Q4 2014 Add 11%
Innoviva INVA · history 2.4% $142.3M 19,815,983 $7.18 Q2 2013 or earlier No change
Forward Pharma FWP · history 2.1% $126.5M 5,367,300 $23.56 Q4 2014 No change
Olin OLN · history 2.0% $117.7M 7,000,000 $16.81 Q3 2015 Buy
Twenty-First Century Fox FOXA · history 1.8% $110.6M 4,097,500 $26.98 Q3 2015 Buy
Veritiv VRTV · history 1.7% $104.1M 2,795,693 $37.24 Q3 2014 Add 13%
AerCap AER · history 1.6% $93.7M 2,450,000 $38.24 Q3 2015 Buy
SunEdison Semiconductor SEMI · history 1.5% $88.3M 8,372,979 $10.54 Q2 2014 Add 1%
Keryx Biopharmaceuticals KERX · history 1.4% $84.5M 25,791,678 $3.28 Q1 2014 No change
Novagold Resources NG · history 1.3% $78.3M 21,688,300 $3.61 Q2 2013 or earlier No change
Theravance Biopharma TBPH · history 1.2% $70.6M 6,420,028 $10.99 Q2 2014 No change
Frontier Communications FTR · history 1.1% $64.1M 13,500,000 $4.75 Q2 2015 No change
ChipMOS IMOS · history 1.0% $61.6M 3,751,853 $16.42 Q2 2013 or earlier Add 14%
KLX KLXI · history 0.9% $53.6M 1,500,000 $35.74 Q1 2015 No change
Citigroup C.WS · warrants · history 0.8% $47.2M 102,553,207 $0.46 Q2 2013 or earlier No change
LifeLock LOCK · history 0.7% $39.1M 4,460,760 $8.76 Q3 2015 Buy
Bellatrix Exploration BXE · history 0.6% $36.5M 23,990,500 $1.52 Q4 2014 Add 10%
Onity Group OCN · history 0.6% $34.9M 5,200,427 $6.71 Q3 2014 Reduce 32%
Kosmos Energy KOS · history 0.6% $33.5M 6,000,000 $5.58 Q2 2014 No change
Innoviva INVA.CV · convertible notes · history 0.5% $31.6M 48,230,000 prn Q3 2014 No change
Frontier Communications FTR.PR · preferred · history 0.5% $30.3M 325,000 $93.15 Q2 2015 No change
Paratek Pharmaceuticals PRTK · history 0.5% $29.3M 1,544,498 $19.00 Q4 2014 No change
American International Group AIG.WS · warrants · history 0.5% $28.6M 1,258,496 $22.70 Q2 2013 or earlier No change
Biotie Therapies BITI · history 0.3% $16.4M 1,256,006 $13.09 Q2 2015 Add 44%
Kindred Biosciences KIN · history 0.3% $15.7M 3,013,848 $5.20 Q4 2013 No change
Micron Technology MU · history 0.2% $15.0M 1,000,000 $14.98 Q2 2013 or earlier Reduce 95%
Sunrun RUN · history 0.2% $12.1M 1,170,910 $10.37 Q3 2015 Buy
Pyxus International AOI · history 0.2% $9.3M 458,364 $20.38 Q2 2013 or earlier Reduce 28%
Alon USA Partners ALDW · history 0.1% $8.5M 363,188 $23.31 Q4 2013 Reduce 42%
Sanchez Energy SN · history 0.1% $6.2M 1,000,000 $6.15 Q2 2015 Add 61%
Trilogy Metals TMQ · history 0.1% $3.3M 10,600,758 $0.32 Q2 2013 or earlier No change
Orexigen Therapeutics OREX · history 0.0% $1.5M 821,363 $1.86 Q3 2015 Buy
41 positions100.0%$6.00B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2015, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Energy38.9%
Media & telecom18.7%
Materials11.7%
Health care11.4%
Financials & real estate7.5%
Industrials4.4%
Consumer discretionary3.8%
Technology3.4%
Consumer staples0.2%

What changed from Q2 2015

← Q2 2015 Q4 2015 →